Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia

NATerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

March 16, 2017

Primary Completion Date

April 4, 2024

Study Completion Date

April 4, 2024

Conditions
ThrombocytopeniaCirrhosis
Interventions
DEVICE

TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.

The Interventional Radiologists will inject a dose of Yttrium 90 into your spleen through a small catheter placed in your femoral artery.The entire treatment visit is an outpatient procedure. You will only be admitted to the hospital if the physician deems it necessary due to any symptoms you may experience after the treatment is given. This visit may take 6 to 8 hours.

Trial Locations (1)

60611

Northwestern University/Northwestern Memorial Hospital, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BTG International Inc.

OTHER

lead

Northwestern University

OTHER

NCT03059030 - Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia | Biotech Hunter | Biotech Hunter